Literature DB >> 25966954

Beta1-adrenergic receptor-mediated dilation of rat cerebral artery requires Shaker-type KV1 channels on PSD95 scaffold.

Christopher L Moore1, Samantha J McClenahan1, Hillary M Hanvey1, Dae-Song Jang1, Piper L Nelson1, Biny K Joseph2, Sung W Rhee1.   

Abstract

Postsynaptic density-95 (PSD95) is a scaffolding protein in cerebral vascular smooth muscle cells (cVSMCs), which binds to Shaker-type K(+) (KV1) channels and facilitates channel opening through phosphorylation by protein kinase A. β1-Adrenergic receptors (β1ARs) also have a binding motif for PSD95. Functional association of β1AR with KV1 channels through PSD95 may represent a novel vasodilator complex in cerebral arteries (CA). We explored whether a β1AR-PSD95-KV1 complex is a determinant of rat CA dilation. RT-PCR and western blots revealed expression of β1AR in CA. Isoproterenol induced a concentration-dependent dilation of isolated, pressurized rat CA that was blocked by the β1AR blocker CGP20712. Cranial window imaging of middle cerebral arterioles in situ showed isoproterenol- and norepinephrine-induced dilation that was blunted by β1AR blockade. Isoproterenol-induced hyperpolarization of cVSMCs in pressurized CA was blocked by CGP20712. Confocal images of cVSMCs immunostained with antibodies against β1AR and PSD95 indicated strong colocalization, and PSD95 co-immunoprecipitated with β1AR in CA lysate. Blockade of KV1 channels, β1AR or disruption of PSD95-KV1 interaction produced similar blunting of isoproterenol-induced dilation in pressurized CA. These findings suggest that PSD95 mediates a vasodilator complex with β1AR and KV1 channels in cVSMCs. This complex may be critical for proper vasodilation in rat CA.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25966954      PMCID: PMC4640345          DOI: 10.1038/jcbfm.2015.91

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  44 in total

1.  Targeting of PKA to glutamate receptors through a MAGUK-AKAP complex.

Authors:  M Colledge; R A Dean; G K Scott; L K Langeberg; R L Huganir; J D Scott
Journal:  Neuron       Date:  2000-07       Impact factor: 17.173

2.  A guided tour into subcellular colocalization analysis in light microscopy.

Authors:  S Bolte; F P Cordelières
Journal:  J Microsc       Date:  2006-12       Impact factor: 1.758

3.  Relaxation to transmural nerve stimulation and exogenously added norepinephrine in porcine cerebral vessels. A study utilizing cerebrovascular intrinsic tone.

Authors:  R J Winquist; R C Webb; D F Bohr
Journal:  Circ Res       Date:  1982-12       Impact factor: 17.367

4.  Characterization of the rat basilar artery in vitro.

Authors:  R J Winquist; D F Bohr
Journal:  Experientia       Date:  1982-10-15

5.  Pharmacological coupling and functional role for CGRP receptors in the vasodilation of rat pial arterioles.

Authors:  K W Hong; S E Yoo; S S Yu; J Y Lee; B Y Rhim
Journal:  Am J Physiol       Date:  1996-01

6.  Adrenoreactivity of rat pial arteries under conditions of stabilized systemic blood pressure.

Authors:  O P Gorshkova; V N Shuvaeva; A V Kostylev; D P Dvoretsky
Journal:  Bull Exp Biol Med       Date:  2011-09       Impact factor: 0.804

7.  Enzymatic isolation and characterization of single vascular smooth muscle cells from cremasteric arterioles.

Authors:  W F Jackson; J M Huebner; N J Rusch
Journal:  Microcirculation       Date:  1997-03       Impact factor: 2.628

Review 8.  Cerebral vasodilators.

Authors:  N Toda; T Okamura
Journal:  Jpn J Pharmacol       Date:  1998-04

9.  Quantitative assessment of central beta 1- and beta 2-adrenoceptor regulation using CGP 20712 A.

Authors:  D J Dooley; H Bittiger
Journal:  J Pharmacol Methods       Date:  1987-09

10.  Loss of cerebrovascular Shaker-type K(+) channels: a shared vasodilator defect of genetic and renal hypertensive rats.

Authors:  Ann A Tobin; Biny K Joseph; Hamood N Al-Kindi; Sulayma Albarwani; Jane A Madden; Leah T Nemetz; Nancy J Rusch; Sung W Rhee
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-01       Impact factor: 4.733

View more
  5 in total

Review 1.  β2 Adrenergic Receptor Complexes with the L-Type Ca2+ Channel CaV1.2 and AMPA-Type Glutamate Receptors: Paradigms for Pharmacological Targeting of Protein Interactions.

Authors:  Kwun Nok Mimi Man; Manuel F Navedo; Mary C Horne; Johannes W Hell
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-09-27       Impact factor: 13.820

2.  Pharmacogenetic Associations of β1-Adrenergic Receptor Polymorphisms With Cardiovascular Outcomes in the SPS3 Trial (Secondary Prevention of Small Subcortical Strokes).

Authors:  Oyunbileg Magvanjav; Caitrin W McDonough; Yan Gong; Leslie A McClure; Robert L Talbert; Richard B Horenstein; Alan R Shuldiner; Oscar R Benavente; Braxton D Mitchell; Julie A Johnson
Journal:  Stroke       Date:  2017-03-28       Impact factor: 7.914

Review 3.  Androgen Effects on the Adrenergic System of the Vascular, Airway, and Cardiac Myocytes and Their Relevance in Pathological Processes.

Authors:  Abril Carbajal-García; Jorge Reyes-García; Luis M Montaño
Journal:  Int J Endocrinol       Date:  2020-11-12       Impact factor: 3.257

Review 4.  Ion channel molecular complexes in vascular smooth muscle.

Authors:  Eric A Pereira da Silva; Miguel Martín-Aragón Baudel; Manuel F Navedo; Madeline Nieves-Cintrón
Journal:  Front Physiol       Date:  2022-08-26       Impact factor: 4.755

5.  Metoprolol Impairs β1-Adrenergic Receptor-Mediated Vasodilation in Rat Cerebral Arteries: Implications for β-Blocker Therapy.

Authors:  Christopher L Moore; David S Henry; Samantha J McClenahan; Kelly K Ball; Nancy J Rusch; Sung W Rhee
Journal:  J Pharmacol Exp Ther       Date:  2020-10-25       Impact factor: 4.030

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.